A variety of findings supports the hypothesis that the hypothalamus plays a significant part in the short stature among children with DS (18), specifically the high rate of pathological results in the 12- or 24-hour integrated GH concentration test, the nocturnal GH peak characteristics and the differences between the various stimulation tests that act on different pathways. This evidence concerns the gene GH1 and Dravet syndrome.